| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/15/1999 | WO1998046645A3 Method for the production of antihuman antigen receptors and uses thereof |
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | DE19745151A1 New N-2-Mercapto-3-phenyl-propionyl di:peptide derivatives |
| 04/15/1999 | DE19745146A1 New N-acyl N-acyl-aminoethyl alpha-amino acid derivatives |
| 04/15/1999 | DE19744811A1 Composition for tumour diagnosis and/or therapy |
| 04/15/1999 | DE19744127A1 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 04/15/1999 | CA2308126A1 Modulation of lerk-2-mediated cell adhesion |
| 04/15/1999 | CA2306746A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | CA2306489A1 Benzothiophenes |
| 04/15/1999 | CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | CA2306273A1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 04/15/1999 | CA2306245A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy |
| 04/15/1999 | CA2305685A1 101 human secreted proteins |
| 04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | CA2305045A1 Transgenic animals with knocked-in vec receptor genes and uses thereof |
| 04/15/1999 | CA2304630A1 Taste masked formulations |
| 04/15/1999 | CA2304565A1 Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives |
| 04/15/1999 | CA2304466A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
| 04/15/1999 | CA2304354A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | CA2304152A1 Novel vitamin d analogues |
| 04/15/1999 | CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | CA2303097A1 Polymeric derivatives of camptothecins |
| 04/14/1999 | EP0907737A1 Il-6 mutein |
| 04/14/1999 | EP0907736A2 Cc-type chemokines |
| 04/14/1999 | EP0907733A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 04/14/1999 | EP0907732A2 Polynucleotides encoding secreted proteins |
| 04/14/1999 | EP0907720A1 Combined radiotherapy and immunotherapy to treat cancer |
| 04/14/1999 | EP0907661A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF alpha v beta 5 MEDIATED ANGIOGENESIS |
| 04/14/1999 | EP0907650A1 N- 4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 04/14/1999 | EP0907649A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors |
| 04/14/1999 | EP0907637A1 Phenylalamine derivatives as integrin inhibitors |
| 04/14/1999 | EP0907370A1 Hla-a2.1 binding peptides and their uses |
| 04/14/1999 | EP0907361A1 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| 04/14/1999 | EP0759934B1 Neurotensin antagonist peptides |
| 04/14/1999 | EP0734436B1 Inhibition of dna methyltransferase |
| 04/14/1999 | EP0721456B1 Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them |
| 04/14/1999 | EP0683760B1 Dehydrogenation processes and equipment therefor |
| 04/14/1999 | CN1214052A Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 04/14/1999 | CN1214047A Novel aromatic piperazines derived from substituted cycloazanes, method for prepairing same, pharmaceutical compsns, and use thereof as drugs |
| 04/14/1999 | CN1214041A Sulfonated amino acid derivatives and metalloproteinase inhibitors contg. same |
| 04/14/1999 | CN1213967A Benzothiophenes, formulations containing same, and methods |
| 04/14/1999 | CN1042935C 2-cyano-3-hydroxy acrylic amide compound, its prepn. applications and medicinal compsns. |
| 04/14/1999 | CN1042933C Benzoylguanidine, prepn. of same and application as pharmaceutical and pharmaceutical containing same |
| 04/08/1999 | WO1999016889A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
| 04/08/1999 | WO1999016888A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/08/1999 | WO1999016887A2 Compositions and methods for identifying pkb kinase inhibitors |
| 04/08/1999 | WO1999016877A1 Amino-terminally truncated rantes as chemokine antagonists |
| 04/08/1999 | WO1999016876A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/08/1999 | WO1999016789A1 Apoptosis-related compounds and their use |
| 04/08/1999 | WO1999016784A1 Ras-binding protein (pre1) |
| 04/08/1999 | WO1999016755A1 Novel angiogenesis inhibitors |
| 04/08/1999 | WO1999016745A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | WO1999016742A1 Processes and intermediates useful to make antifolates |
| 04/08/1999 | WO1999016469A1 Altered dna synthesome components as biomarkers for malignancy |
| 04/08/1999 | WO1999016465A1 Method for inhibiting tumor angiogenesis in a living subject |
| 04/08/1999 | WO1999016460A2 Apolipoprotein e/growth factor complexes and methods of use |
| 04/08/1999 | WO1999016452A1 THERAPEUTICALLY EFFECTIVE 1α, 25-DIHYDROXYVITAMIN D3 ANALOGS |
| 04/08/1999 | WO1999016451A1 Use of vitamin d derivatives to enhance efficacy of cytotoxic agents |
| 04/08/1999 | WO1999016438A1 Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function |
| 04/08/1999 | WO1999016319A1 A fagopyrum cymosum (trev.) meisn composition, method to prepare and analyze the same and uses thereof |
| 04/08/1999 | WO1999010322B1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 04/08/1999 | WO1999006114A3 Use of taurolidine or taurultam for the manufacture of a medicament for the prevention of metastases |
| 04/08/1999 | WO1999005269A3 Transcriptional silencer protein nrf |
| 04/08/1999 | WO1999003882A3 Human leukocyte calcium activated potassium channel polypeptide |
| 04/08/1999 | WO1999003823A3 Novel polyamine analogues as therapeutic and diagnostic agents |
| 04/08/1999 | WO1999003488A3 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 04/08/1999 | WO1999000113A9 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 04/08/1999 | WO1998056919A9 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/08/1999 | WO1998056910A9 DETECTION OF LOSS OF THE WILD-TYPE huBUB1 GENE |
| 04/08/1999 | WO1998055638A9 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof |
| 04/08/1999 | WO1998055103A9 Anti-tumoral therapy agent |
| 04/08/1999 | WO1998049321A8 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors |
| 04/08/1999 | CA2305686A1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/08/1999 | CA2305681A1 Apoptosis-related compounds and their use |
| 04/08/1999 | CA2305625A1 Altered dna synthesome components as biomarkers for malignancy |
| 04/08/1999 | CA2305140A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | CA2305017A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/08/1999 | CA2304827A1 Amino-terminally truncated rantes as chemokine antagonists |
| 04/08/1999 | CA2304763A1 A fagopyrum cymosum (trev.) meisn composition, method to prepare and analyze the same and uses thereof |
| 04/08/1999 | CA2304720A1 Apolipoprotein e/growth factor complexes and methods of use |
| 04/08/1999 | CA2304656A1 Processes and intermediates useful to make antifolates |
| 04/08/1999 | CA2304209A1 Ras-binding protein (pre1) |
| 04/08/1999 | CA2304056A1 Therapeutically effective 1.alpha., 25-dihydroxyvitamin d3 analogs |
| 04/08/1999 | CA2303830A1 Novel angiogenesis inhibitors |
| 04/08/1999 | CA2303401A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
| 04/08/1999 | CA2298854A1 Compositions and methods for identifying pkb kinase inhibitors |
| 04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
| 04/08/1999 | CA2213680A1 Nucleotide sequences and protein sequences |
| 04/07/1999 | EP0906919A2 Novel integrin-binding peptides |
| 04/07/1999 | EP0906441A1 Antitumour cellular compositions expressing at least three transgenes |
| 04/07/1999 | EP0906433A1 Protein tyrosine phosphatases of hematopoietic cells |
| 04/07/1999 | EP0906426A1 Antibodies to the ed-b domain of fibronectin, their construction and uses |
| 04/07/1999 | EP0906419A2 Peptide ligands of the urokinase receptor |
| 04/07/1999 | EP0906317A1 Novel water-soluble c-ring analogues of 20(s)-camptothecin |
| 04/07/1999 | EP0906316A1 Novel water-soluble analogues of 20(s)-camptothecin |
| 04/07/1999 | EP0906305A1 1-(1h-pyrrol-2-ylmethyl)-2-piperidone as cell migration inhibitor |
| 04/07/1999 | EP0906303A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 04/07/1999 | EP0906295A1 Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents |
| 04/07/1999 | EP0906286A1 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick |
| 04/07/1999 | EP0906276A1 Novel vitamin d analogues |